Thermo Fisher Scientific (TMO) Inventory (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Inventory for 18 consecutive years, with $5.6 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 1.22% year-over-year to $5.6 billion; the trailing twelve-month figure through Jun 2026 stood at $5.6 billion (up 1.22% YoY), and the FY2025 full-year result was $5.4 billion, up 8.98% from the prior year.
• Inventory rose to $5.6 billion in Q2 2026 per TMO's latest filing, from $5.5 billion in the prior quarter.
• Across five years, Inventory topped out at $5.7 billion in Q3 2025 and bottomed at $5.0 billion in Q4 2024.
• Historically, Inventory has averaged $5.5 billion across 5 years, with a median of $5.5 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: Inventory gained 26.28% in 2022, then dropped 9.69% in 2023.
• Over 5 years, Inventory stood at $5.6 billion in 2022, then fell by 9.69% to $5.1 billion in 2023, then slipped by 2.16% to $5.0 billion in 2024, then climbed by 8.98% to $5.4 billion in 2025, then grew by 3.72% to $5.6 billion in 2026.
• According to Business Quant data, Inventory over the past three periods registered $5.6 billion, $5.5 billion, and $5.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.